Company · CIK 0001770787 · SIC 3826 — Laboratory Analytical Instruments · Nasdaq
10x Genomics, Inc. · TXG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 4:30 pm EDT | Shehnaaz SulimanDirector | 5,723 | $81.19 | $464,668 | 23,792 | −19.4% | 10b5-1 |
| Sep 22, 2026 SForm 4 → | Sep 24, 4:29 pm EDT | Serge SaxonovChief Executive Officer, Director | 25,000 | $81.22 | $2,030,562 | 1,050,249 | −2.33% | 10b5-1 |
| Sep 9, 2026 SForm 4 → | Sep 11, 4:47 pm EDT | Adam TaichChief Financial Officer | 46,388 | $64.57 | $2,995,470 | 316,344 | −12.8% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 8, 7:00 pm EDT | John R StuelpnagelDirector | 20,000 | $61.75 | $1,235,072 | 328,436 | −5.74% | |
| Sep 1, 2026 GForm 4 → | Sep 3, 5:19 pm EDT | Serge SaxonovChief Executive Officer, Director | 100 | — | — | 1,075,249 | — | |
| Aug 26, 2026 SForm 4 → | Aug 28, 7:22 pm EDT | Serge SaxonovChief Executive Officer, Director | 10,486 | $63.69 | $667,901 | 1,075,349 | −0.97% | 10b5-1 |
| Aug 24, 2026 SForm 4 → | Aug 26, 4:46 pm EDT | Serge SaxonovChief Executive Officer, Director | 18,545 | $63.02 | $1,168,775 | 1,085,835 | −1.68% | |
| Aug 24, 2026 SForm 4 → | Aug 26, 4:44 pm EDT | Adam TaichChief Financial Officer | 17,166 | $63.02 | $1,081,853 | 362,732 | −4.52% | |
| Aug 24, 2026 SForm 4 → | Aug 26, 4:43 pm EDT | Benjamin J. HindsonSee Remarks, Director | 13,818 | $63.02 | $870,860 | 488,182 | −2.75% | |
| Aug 24, 2026 SForm 4 → | Aug 26, 4:42 pm EDT | Shehnaaz SulimanDirector | 2,207 | $63.65 | $140,478 | 29,515 | −6.96% | 10b5-1 |
| Aug 20, 2026 GForm 4 → | Aug 24, 4:16 pm EDT | Serge SaxonovChief Executive Officer, Director | 4,000 | — | — | 1,104,380 | — | |
| Aug 13, 2026 SForm 4 → | Aug 17, 4:08 pm EDT | Sarah A. TeichmannDirector | 7,551 | $57.25 | $432,279 | 28,058 | −21.2% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 4:11 pm EDT | John R StuelpnagelDirector | 20,000 | $57.75 | $1,155,055 | 348,436 | −5.43% | |
| Jun 22, 2026 SForm 4 → | Jun 24, 4:22 pm EDT | Serge SaxonovChief Executive Officer, Director | 30,000 | $34.44 | $1,033,269 | 1,108,380 | −2.64% | 10b5-1 |
| Jun 16, 2026 SForm 4 → | Jun 18, 4:08 pm EDT | Shehnaaz SulimanDirector | 5,723 | $32.63 | $186,756 | 31,722 | −15.3% | 10b5-1 |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:27 pm EDT | Sarah A. TeichmannDirector | 8,829 | — | — | 35,609 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:26 pm EDT | Shehnaaz SulimanDirector | 8,829 | — | — | 37,445 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:26 pm EDT | John R StuelpnagelDirector | 8,829 | — | — | 368,436 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:25 pm EDT | Kimberly J PopovitsDirector | 8,829 | — | — | 37,445 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:24 pm EDT | Alan MateoDirector | 8,829 | — | — | 85,877 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 7:23 pm EDT | Sridhar KosarajuDirector | 8,829 | — | — | 65,278 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.